Skip to main content
. Author manuscript; available in PMC: 2015 Sep 15.
Published in final edited form as: Toxicol Appl Pharmacol. 2014 Jun 3;279(3):266–274. doi: 10.1016/j.taap.2014.05.010

Figure 5. JNK inhibitor SP600125 partially protects against APAP-induced cell death in PHH.

Figure 5

JNK inhibitor SP600125 using 0.2% DMSO as the vehicle was administered either as (A) a co-treatment with APAP or (B) a 3-hour post-treatment after APAP. (C) Western blotting was performed to verify the efficacy of SP600125. Data represent mean ± SE from experiments using cells from 6 donors. #P < 0.05 (compared with APAP+Veh group).